Biliary Stents Market Report: Market Size & Forecast 2026

Biliary stents are tubular implants placed during endoscopic procedures to restore bile flow in patients suffering from biliary obstructions caused by strictures, stones, or malignancies. The market covers both metal stents, typically constructed from stainless steel or nitinol alloys, and plastic stents made from polyethylene or similar polymers for shorter-term applications. Current market valuation stands near $0.45 billion globally in 2025, with projections indicating steady expansion through 2034.

• •Global market size estimated at approximately $0.45 billion in 2025
• •Expected to expand at roughly 5.8% CAGR through the early 2030s
• •Primary clinical applications include malignant biliary obstruction and benign strictures

The aging global population is increasing demand as elderly patients face elevated risks of biliary diseases, gallstones, and cancers requiring stent interventions. Rising prevalence of pancreatic cancer, cholangiocarcinoma, and complications from gallstone disease is expanding the patient pool requiring these devices. Technological improvements in stent design, including covered metal stents with reduced tissue ingrowth, are improving clinical outcomes and physician adoption. Growing healthcare infrastructure investment in developing regions and expanding access to endoscopic retrograde cholangiopancreatography procedures further support market growth.

• •Increasing incidence of pancreatic and bile duct cancers driving higher procedure volumes
• •Growing preference for minimally invasive endoscopic procedures over open surgical alternatives
• •Rising geriatric population with higher prevalence of biliary tract disorders and complications

The market is segmented by product type into metal stents, including covered and uncovered varieties for longer-term use, and plastic stents primarily deployed for benign conditions or as bridges to surgery. By application, malignant obstruction represents the dominant segment given cancer prevalence, while benign strictures and post-operative leaks constitute smaller but meaningful categories. Geographically, North America holds the largest market share attributed to advanced healthcare infrastructure, high procedure volumes, and favorable reimbursement frameworks. The Asia-Pacific region is forecasted to exhibit the strongest growth momentum as healthcare access and spending increase across China, India, and Southeast Asian markets.

• •Metal stents dominate the malignant obstruction segment due to superior long-term patency
• •North America leads globally with established endoscopic capabilities and high disease burden
• •Asia-Pacific emerging as fastest-growing region driven by rising healthcare expenditure and improved access

What are the recent trends and outlook?

Next-generation stent technologies including partially and fully biodegradable biliary stents, as well as drug-eluting metal stents designed to reduce restenosis, represent emerging product categories gaining clinical attention. The trend toward ambulatory care settings and outpatient endoscopy centers is expanding procedural volumes and addressable market opportunities across developed and emerging markets. Looking forward to 2034, market observers anticipate continued product innovation alongside potential consolidation among mid-tier manufacturers seeking to broaden their GI portfolios. Companies are increasingly investing in clinical studies demonstrating superior safety profiles and extended patency to differentiate their offerings in an evolving treatment landscape.

• •Development of bioabsorbable stents aimed at eliminating need for removal gaining clinical momentum
• •Expansion of outpatient endoscopy centers increasing procedural accessibility and market reach
• •Industry consolidation and product innovation expected to reshape competitive positioning through 2034